ClinicalTrialsFinder

Sodium-glucose Cotransporter-2 Inhibitor Clinical Trials in Hong Kong

1 recruitingHong Kong, Hong Kong

Showing 1–1 of 1 trials

Recruiting
Phase 2

Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients

End Stage Renal Disease on DialysisPeritoneal Dialysis ComplicationResidual Kidney Function+1 more
Chinese University of Hong Kong48 enrolled1 locationNCT06483074